Our findings enhance the understanding of ONOO− reduction by the E2 domain of APP, expand our knowledge of copper proteins in mitigating oxidative stress, and elucidate their physiological and pathological roles, particularly in Alzheimer's disease. This evidence concerns the gene APP and Alzheimer disease.